Tracking Patient Outcomes to Improve Access to Medicines in LMICS: Report by Access to Medicine Foundation

The Max Foundation posted on LinkedIn:

“This report by Access to Medicine Foundation is a crucial step in establishing industry standards for tracking patient outcomes in access programs. We share this commitment as it is our belief that it is critical to track every patient to ensure they get the medicines they need. By monitoring individual patient outcomes, we can better assess the impact of these initiatives and ensure that medicines are reaching those who need them most.

We applaud the first-of-its-kind report which addresses the critical issue of how pharma companies monitor the effectiveness of access programs, particularly in low- and middle-income countries.

You can download the full report here.”

Source: The Max Foundation/LinkedIn